ArticleFrontiers in medicine2025

The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab.

Jing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.